Good morning, everyone, and how are you today? We hope the weekend was relaxing and refreshing, because now, the usual routine is resuming. Yes, there is no choice - meetings and deadlines and what-not await. And so, we are coping, as usual, with a needed cup of stimulation and invite you to join us. As always, we also offer a few interesting items to help you along. Hope your day goes well and let us know if you hear anything interesting...
Ranbaxy To Get Guidance On Remediation For Troubled Plant (Business Standard)
Gilead And Abbott Release Hepatitis C Data (TheStreet)
Pfizer To Plead Guilty In Rapamune Settlement (Dow Jones)
FDA Has New Safety Hurdle For Opioid Constipation Drugs (TheStreet)
Pfizer Slammed For Not Paying UK Taxes (Daily Mail)
Clovis Ends Development Of Pancreatic Cancer Drug (Bloomberg News)
India Pushes Japan For Faster Drug Approvals (PharmaBiz)
Merck Hepatitis C Drug Shows Promise In Trial (Wall Street Journal)
Celgene's Abraxane Boosts Pancreatic Cancer Survival (TheStreet)
Novartis Drug Succeeds In Liver Transplant Trial (Reuters)
Third Person Dies After Plant Explosion In Quebec (National Post)
Glaxo Malaria Vaccines Suffer Trial Setback (Pharma Times)
Illegally Imported Meds Causes Scandal In Lebabon (Now Lebanon)
EDITOR'S NOTE: Please check this post for updates
sunrise pic thx to benimoto on flickr